Veradermics Net Income decreased by 119.6% to -$27.23M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 119.6%, from -$12.40M to -$27.23M. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | -$6.62M | -$6.62M | -$6.62M | -$6.62M | -$12.40M | -$27.23M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -87.3% | -119.6% |
| YoY Change | — | — | — | — | -87.3% | -119.6% |
| Segment | Q1 '26 |
|---|---|
| Reportable Segment | -$27.23M |
| Total | -$27.23M |